Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Plos One
|
September 14, 2023
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)
Karen Leroy, Clarisse Audigier Valette, Jérôme Alexandre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Luis Teixeira, Jacques Medioni, Julie Garibal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients
Antonin Schmitt, Laurence Gladieff, Amélie Lansiaux, et al.
JAMA Network Open
|
April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
Philip C Schouten, Sandra Schmidt, Kerstin Becker, et al.
British Journal of Cancer
|
January 25, 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, et al.
Gynecologic Oncology
|
February 6, 2022
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial
Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Robin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Cancer Discovery
|
June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations
Sumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
The New England Journal of Medicine
|
August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers
Lori J Wirth, Eric Sherman, Bruce Robinson, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Plos One
|
September 14, 2023
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)
Karen Leroy, Clarisse Audigier Valette, Jérôme Alexandre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Luis Teixeira, Jacques Medioni, Julie Garibal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients
Antonin Schmitt, Laurence Gladieff, Amélie Lansiaux, et al.
JAMA Network Open
|
April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
Philip C Schouten, Sandra Schmidt, Kerstin Becker, et al.
British Journal of Cancer
|
January 25, 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, et al.
Gynecologic Oncology
|
February 6, 2022
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial
Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Robin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Cancer Discovery
|
June 1, 2018
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations
Sumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, et al.
The New England Journal of Medicine
|
August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers
Lori J Wirth, Eric Sherman, Bruce Robinson, et al.
Page
of 6